SCNI

#5164
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.5914 USD
-0.10%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.5901
0.5914
Rango anual
0.5500
1.0499
Cambio diario
-0.10%
Variación mensual
-16.82%
Variación en los últimos 6 meses
-21.79%
Cambio anual
-21.79%
Cierres anteriores
0.5920
Abrir
0.5901
Bid
Ask
Mínimo
0.5901
High
0.5914
Volumen
2
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 2.0511 M
  • Employee 31
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
791.22
Relación precio/flujo de caja
5 072.94

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Noticias